Some group of people really like to hype things upfor publicity, in this case, changing the name of Retatrutide to GLP-3
A clinical trial that just began dosing patients at Johns Hopkins is testing something the diabetes world has suspected for years: that the same class of drugs millions of people take to manage blood sugar may be quietly protecting the brain from shrinking
Overcome weight-loss plateaus: Nearly everyone hits a plateau at some point a few weeks where the scale doesnt budge
Its personalized digestive guidance and medical oversight offered at Pure Medical Spa to help patients stay comfortable during treatment
"It would not be correct to describe this investigatory medicine as Ozempic because it is an unlicensed investigatory use of semaglutide, and Ozempic is the brand name for it in Type 2 diabetes," says Prof Naji Tabet, the director of the Centre for Dementia Studies at Brighton and Sussex Medical School
Check the GLP-1 average weight loss per month guide for benchmarking your progress against typical trajectories
